These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 30778141)

  • 1. Cancer-associated fibroblasts in gastrointestinal cancer.
    Kobayashi H; Enomoto A; Woods SL; Burt AD; Takahashi M; Worthley DL
    Nat Rev Gastroenterol Hepatol; 2019 May; 16(5):282-295. PubMed ID: 30778141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer.
    Huang J; Tsang WY; Li ZH; Guan XY
    Cell Mol Gastroenterol Hepatol; 2023; 16(4):503-511. PubMed ID: 37451403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.
    Bu L; Baba H; Yoshida N; Miyake K; Yasuda T; Uchihara T; Tan P; Ishimoto T
    Oncogene; 2019 Jun; 38(25):4887-4901. PubMed ID: 30816343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SnapShot: Cancer-Associated Fibroblasts.
    Park D; Sahai E; Rullan A
    Cell; 2020 Apr; 181(2):486-486.e1. PubMed ID: 32302576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated fibroblasts: Key criminals of tumor pre-metastatic niche.
    Dong G; Chen P; Xu Y; Liu T; Yin R
    Cancer Lett; 2023 Jul; 566():216234. PubMed ID: 37236390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer associated fibroblasts tailored tumor microenvironment of therapy resistance in gastrointestinal cancers.
    Sun Y; Wang R; Qiao M; Xu Y; Guan W; Wang L
    J Cell Physiol; 2018 Sep; 233(9):6359-6369. PubMed ID: 29334123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts.
    Ziani L; Chouaib S; Thiery J
    Front Immunol; 2018; 9():414. PubMed ID: 29545811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts in hepatocellular carcinoma.
    Kubo N; Araki K; Kuwano H; Shirabe K
    World J Gastroenterol; 2016 Aug; 22(30):6841-50. PubMed ID: 27570421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy.
    Liu T; Han C; Wang S; Fang P; Ma Z; Xu L; Yin R
    J Hematol Oncol; 2019 Aug; 12(1):86. PubMed ID: 31462327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment.
    Al-Bzour NN; Al-Bzour AN; Ababneh OE; Al-Jezawi MM; Saeed A; Saeed A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between cancer-associated fibroblasts and T-cells: functional crosstalk with targeting and biomarker potential.
    Milosevic V; Östman A
    Ups J Med Sci; 2024; 129():. PubMed ID: 38863724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies.
    Mhaidly R; Mechta-Grigoriou F
    Semin Immunol; 2020 Apr; 48():101417. PubMed ID: 33077325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning foes to friends: targeting cancer-associated fibroblasts.
    Chen X; Song E
    Nat Rev Drug Discov; 2019 Feb; 18(2):99-115. PubMed ID: 30470818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.
    Chen PY; Wei WF; Wu HZ; Fan LS; Wang W
    Front Immunol; 2021; 12():671595. PubMed ID: 34305902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic Radiopharmaceuticals Targeting Cancer-Associated Fibroblasts.
    Zhuravlev F
    Curr Radiopharm; 2021; 14(4):374-393. PubMed ID: 33357190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1α is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer.
    Zhang Y; Bian Y; Wang Y; Wang Y; Duan X; Han Y; Zhang L; Wang F; Gu Z; Qin Z
    J Cell Mol Med; 2021 Jun; 25(12):5457-5469. PubMed ID: 33943003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast diversity and plasticity in the tumor microenvironment: roles in immunity and relevant therapies.
    Xu Y; Li W; Lin S; Liu B; Wu P; Li L
    Cell Commun Signal; 2023 Sep; 21(1):234. PubMed ID: 37723510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the Tumor Microenvironment in Liver Cancer Progression.
    Muppala S
    Crit Rev Oncog; 2020; 25(1):1-9. PubMed ID: 32865906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
    Patel AK; Singh S
    Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.